glp 1 agonist and heart failure Impact of GLP-1 receptor agonists on cardiovascular outcomes in with preserved ejection fraction (HFpEF): systematic review meta-analysis | Clinical Research in Cardiology Glucagon-like peptide 1(GLP-1) receptor agonists
Description
doi:10.1016/j.bbrc.2008.08.052 322
Incapsula incident ID: 344000140039499496-167273050463011729
Similarly, a 2021 review of phase III clinical trials concluded that GLP-1 medications reduce A1c
There are also data that suggest that bile acid malabsorption can be successfully treated with GLP-1RA 103 and this may be an important confounder in registry studies that was not corrected for
Generic companies are preparing, filing dossiers, and positioning but none of them are actually launching anything meaningful in those markets until the early 2030s
Lancet 2019;394:3950.ArticlePubMed 27
